These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 32134631

  • 21. Fighting Cholera One-on-One: The Development and Efficacy of Multivalent Cholera-Toxin-Binding Molecules.
    Zuilhof H.
    Acc Chem Res; 2016 Feb 16; 49(2):274-85. PubMed ID: 26760438
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Endocytosis of cholera toxin in GERL-like structures of murine neuroblastoma cells pretreated with GM1 ganglioside. Cholera toxin internalization into Neuroblastoma GERL.
    Joseph KC, Stieber A, Gonatas NK.
    J Cell Biol; 1979 Jun 16; 81(3):543-54. PubMed ID: 457774
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation.
    Kaittanis C, Banerjee T, Santra S, Santiesteban OJ, Teter K, Perez JM.
    Bioconjug Chem; 2011 Feb 16; 22(2):307-14. PubMed ID: 21226491
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin.
    Katz HR, Levine JS, Austen KF.
    J Immunol; 1987 Sep 01; 139(5):1640-6. PubMed ID: 2957431
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates.
    Dawson RM.
    J Appl Toxicol; 2005 Sep 01; 25(1):30-8. PubMed ID: 15669043
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene.
    Garcia-Hartjes J, Bernardi S, Weijers CA, Wennekes T, Gilbert M, Sansone F, Casnati A, Zuilhof H.
    Org Biomol Chem; 2013 Jul 14; 11(26):4340-9. PubMed ID: 23689250
    [Abstract] [Full Text] [Related]

  • 34. The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane.
    Gizurarson S, Tamura S, Kurata T, Hasiguchi K, Ogawa H.
    Vaccine; 1991 Nov 14; 9(11):825-32. PubMed ID: 1759504
    [Abstract] [Full Text] [Related]

  • 35. Interaction of cholera toxin and Escherichia coli enterotoxin with isolated intestinal epithelial cells.
    Hyun CS, Kimmich GA.
    Am J Physiol; 1984 Dec 14; 247(6 Pt 1):G623-31. PubMed ID: 6095676
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
    Lian T, Bui T, Ho RJ.
    Vaccine; 1999 Nov 12; 18(7-8):604-11. PubMed ID: 10547418
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.